Actively Recruiting
Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital
Led by Port Said University · Updated on 2024-06-13
600
Participants Needed
2
Research Sites
48 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
* Review key history and clinical examination findings of cases with CLABSI. * Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI. * Determine antibiotic biogram of each organism isolated * Determine the prevalence of occurrence of Primary or secondary Blood stream infection, causing microorganism, and predisposing factors.
CONDITIONS
Official Title
Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with sepsis based on medical history, lab investigations, and clinical picture
- Both sexes and all age groups are eligible
You will not qualify if you...
- Patients with sepsis who have received non-beta lactam antibiotics in the past 24 hours
- Blood samples contaminated by microbial flora will be rejected
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Prof. Refat Sadeq
Port Said, Egypt, 22223
Actively Recruiting
2
Faculty of Medicine Portsaid Uni
Port Said, Egypt
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here